SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-001219
Filing Date
2017-01-09
Accepted
2017-01-09 08:00:44
Documents
25
Period of Report
2017-01-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v456504_8-k.htm 8-K 14223
2 EXHIBIT 99.1 v456504_ex99-1.htm EX-99.1 24824
3 GRAPHIC image_001.jpg GRAPHIC 79366
4 GRAPHIC image_002.jpg GRAPHIC 119594
5 GRAPHIC image_003.jpg GRAPHIC 106942
6 GRAPHIC image_004.jpg GRAPHIC 65441
7 GRAPHIC image_005.jpg GRAPHIC 72360
8 GRAPHIC image_006.jpg GRAPHIC 59086
9 GRAPHIC image_007.jpg GRAPHIC 83773
10 GRAPHIC image_008.jpg GRAPHIC 92940
11 GRAPHIC image_009.jpg GRAPHIC 80826
12 GRAPHIC image_010.jpg GRAPHIC 81379
13 GRAPHIC image_011.jpg GRAPHIC 85422
14 GRAPHIC image_012.jpg GRAPHIC 97048
15 GRAPHIC image_013.jpg GRAPHIC 83776
16 GRAPHIC image_014.jpg GRAPHIC 82710
17 GRAPHIC image_015.jpg GRAPHIC 90090
18 GRAPHIC image_016.jpg GRAPHIC 74412
19 GRAPHIC image_017.jpg GRAPHIC 70096
20 GRAPHIC image_018.jpg GRAPHIC 74120
21 GRAPHIC image_019.jpg GRAPHIC 69535
22 GRAPHIC image_020.jpg GRAPHIC 73107
23 GRAPHIC image_021.jpg GRAPHIC 98176
24 GRAPHIC image_022.jpg GRAPHIC 78077
25 GRAPHIC image_023.jpg GRAPHIC 62261
  Complete submission text file 0001144204-17-001219.txt   2633250
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 17515828
SIC: 2836 Biological Products, (No Diagnostic Substances)